跳至主要内容
临床试验/ACTRN12605000137695
ACTRN12605000137695
终止
3 期

A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients

Australasian Leukaemia and Lymphoma Group0 个研究点目标入组 240 人2005年8月12日

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Australasian Leukaemia and Lymphoma Group
入组人数
240
状态
终止
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2005年8月12日
结束日期
2009年12月31日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
Australasian Leukaemia and Lymphoma Group

入排标准

入选标准

  • 1\.Undergoing allogeneic haematopoietic stem cell transplantation (HSCT) for any reason OR Undergoing intensive combination chemotherapy for acute myeloid leukaemia (AML) or acute lymphoblastic leukaemia (ALL). 2\.Has given written informed consent. Non\-English speaking patients are eligible once written informed consent is obtained via the appropriate interpreter.

排除标准

  • 1\.Other immunocompromised states (e.g. HIV infection, solid organ transplantation, autoimmune conditions treated with immunosuppressants etc.) besides those outlined in the inclusion criteria above. 2\.Currently enrolled in an antifungal treatment trial (not an antifungal prophylaxis trial). 3\.Past history of proven or probable IA (as per standardized definitions) during a previous cycle of chemotherapy. 4\.Currently have active IA or other active invasive fungal infection. 5\.Prior enrolment in this study.

结局指标

主要结局

未指定

相似试验